Regulation (EC) No 273/2004 of the European Parliament and of the Council of 11 February 2004 on drug precursors (Text with EEA relevance)
Date: 2004-02-11
Institutions: Council of the European Union, European Parliament
Subjects: administrative cooperation, drug addiction, drug traffic, intra-EU trade, labelling, market approval, psychotropic substance

18.2.2004

EN

Official Journal of the European Union

L 47/1

I

(Acts whose publication is obligatory)

REGULATION (EC) No 273/2004 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL

of 11 February 2004

on drug precursors

(Text with EEA relevance)

THE EUROPEAN PARLIAMENT AND THE COUNCIL OF THE
EUROPEAN UNION,

Having regard to the Treaty establishing the European Com-
munity, and in particular Article 95 thereof,

Having regard to the proposal from the Commission (1),

Having regard to the opinion of the European Economic and
Social Committee (2),

Acting in accordance with the procedure laid down in Article
251 of the Treaty (3),

Whereas:

(1)

(2)

(3)

The United Nations Convention against Illicit Traffic in
Narcotic Drugs and Psychotropic Substances, adopted in
Vienna on 19 December 1988, hereinafter referred to as
the ‘United Nations Convention’, was concluded by the
Community by Council Decision 90/611/EEC (4).

The requirements of Article 12 of the United Nations
Convention in respect of trade in drug precursors (i.e.
substances frequently used in the illicit manufacture of
narcotic drugs and psychotropic substances) have been
implemented, as far as trade between the Community
and third countries is concerned, by Council Regulation
(EEC) No 3677/90 of 13 December 1990 laying down
measures to be taken to discourage the diversion of
certain substances to the illicit manufacture of narcotic
drugs and psychotropic substances (5).

Article 12 of the United Nations Convention envisages
adoption of appropriate measures to monitor the manu-
facture and distribution of precursors. This requires the
adoption of measures relating to the trade in precursors
among Member States. Such measures were introduced

(1) OJ C 20 E, 28.1.2003, p. 160.
(2) OJ C 95, 23.4.2003, p. 6.
(3) Opinion of the European Parliament of 11 March 2003 (not yet
published in the Official Journal), Council common position of 29
September 2003 (OJ C 277 E, 18.11.2003, p. 31) and position of
the European Parliament of 16 December 2003 (not yet published
in the Official Journal).

(4) OJ L 326, 24.11.1990, p. 56.
(5) OJ L 357, 20.12.1990, p. 1. Regulation as last amended by
Commission Regulation (EC) No 1232/2002 (OJ L 180, 10.7.2002,
p. 5).

(4)

(5)

(6)

(7)

by Council Directive 92/109/EEC of 14 December 1992
on the manufacture and the placing on the market of
certain substances used in the illicit manufacture of
narcotic drugs and psychotropic substances (6). To better
ensure that harmonised rules are applied at the same
time in all Member States, a regulation is considered to
be more adequate than the current Directive.

the enlargement of

In the context of
the European
Union, it is important to replace Directive 92/109/EEC
by a regulation, as each modification of that Directive
and its Annexes would trigger national implementation
measures in 25 Member States.

its 35th session in 1992,

By decisions taken at
the
United Nations Commission on Narcotic Drugs included
additional substances in the tables of the Annex to the
United Nations Convention. Corresponding provisions
should be laid down in this Regulation in order to detect
possible cases of illicit diversion of drug precursors in
the Community and to ensure that common monitoring
rules are applied in the Community market.

The provisions of Article 12 of
the United Nations
Convention are based on a system of monitoring trade
trade in these
in the substances in question. Most
substances is entirely lawful. The documentation of
consignments and labelling of these substances should
be sufficiently explicit.
is furthermore important,
whilst providing competent authorities with the neces-
sary means of action, to develop, within the spirit of the
United Nations Convention, mechanisms based on close
cooperation with the operators concerned and on the
development of intelligence gathering.

It

it

The measures applicable to sassafras oil are currently
interpreted in different ways in the Community, since in
some Member States
regarded as a mixture
is
containing Safrole and is therefore controlled, while
other Member States regard it as a natural product not
subject
Inserting a reference to natural
products in the definition of ‘scheduled substances’ will
resolve this discrepancy and therefore allow controls to
be applied to sassafras oil; only natural products from
which scheduled substances can be extracted easily
should be covered by the definition.

to controls.

(6) OJ L 370 19.12.1992, p. 76. Directive as last amended by Regu-
lation (EC) No 1882/2003 of the European Parliament and of the
Council (OJ L 284, 31.10.2003, p. 1).

L 47/2

EN

Official Journal of the European Union

18.2.2004

(8)

(9)

Substances commonly used in the illicit manufacture of
narcotic drugs or psychotropic substances should be
listed in an Annex.

It should be ensured that the manufacture or use of
certain scheduled substances listed in Annex I is subject
to possession of a licence. In addition, the supply of
such substances should be permitted only where the
persons to whom they are to be supplied are holders of
a licence and have signed a customer declaration. The
detailed rules
customer declaration
concerning the
should be laid down in Annex III.

(10) Measures should be adopted to encourage operators to
notify the competent authorities of suspect transactions
involving scheduled substances listed in Annex I.

(11) Measures should be adopted in order to guarantee better
scheduled

intra-Community

trade

in

control
substances listed in Annex I.

of

(12) All transactions leading to the placing on the market of
scheduled substances of categories 1 and 2 of Annex I
should be properly documented. Operators should notify
the competent authorities of any suspect transactions
involving the substances listed in Annex I. However,
exemptions
involving
should apply to transactions
substances of category 2 of Annex I where the quantities
involved do not exceed those indicated in Annex II.

(13) A significant number of other substances, many of them
traded legally in large quantities, have been identified as
precursors to the illicit manufacture of synthetic drugs
and psychotropic substances. To subject these substances
to the same strict controls as those listed in Annex I
would present an unnecessary obstacle to trade involving
licences to operate and documentation of transactions.
Therefore, a more flexible mechanism at Community
level
should be established whereby the competent
authorities in the Member States are notified of such
transactions.

(14)

The introduction of a cooperation procedure is provided
for in the European Union action plan against drugs
approved by the European Council of Santa Maria da
Feira on 19 and 20 June 2000. In order to support
cooperation between the competent authorities of the
Member States and the chemicals industry, in particular

(15)

(16)

(17)

with regard to substances which, although not referred
to in this Regulation, might be used in the illicit manu-
facture of synthetic drugs and psychotropic substances,
guidelines should be drawn up aimed at helping the
chemical industry.

It is appropriate to make provision for the Member
States to lay down rules on penalties applicable for
infringement of the provisions of this Regulation. Given
that the trade in drug precursors may lead to the illicit
manufacture of
and psychotropic
synthetic drugs
substances, Member States should be free to choose the
most dissuasive penalties available under their national
legislation.

The measures necessary for the implementation of this
Regulation should be adopted in accordance with
Council Decision 1999/468/EC of 28 June 1999 laying
down the procedures for the exercise of implementing
powers conferred on the Commission (1).

this Regulation, namely the
Since the objectives of
harmonised monitoring of the trade in drug precursors
and the avoidance of its diversion to the illicit manufac-
ture of synthetic drugs and psychotropic substances,
cannot be sufficiently achieved by the Member States
and can therefore, by reason of the international and
changeable nature of such trade, be better achieved at
Community level, the Community may adopt measures,
in accordance with the principle of subsidiarity as set
out in Article 5 of the Treaty. In accordance with the
principle of proportionality, as set out in that Article,
this Regulation does not go beyond what is necessary in
order to achieve those objectives.

(18)

Council Directive 92/109/EEC, Commission Directives
93/46/EEC (2), 2001/8/EC (3) and 2003/101/EC (4) and
Commission Regulations (EC) No 1485/96 (5) and (EC)
No 1533/2000 (6) should be repealed,

(1) OJ L 184, 17.7.1999, p. 23.
(2) Commission Directive 93/46/EEC of 22 June 1993 replacing and
modifying the Annexes to Council Directive 92/109/EEC on the
manufacture and placing on the market of certain substances used
in the illicit manufacture of narcotic drugs and psychotropic
substances (OJ L 159, 1.7.1993, p. 134).

(3) Commission Directive 2001/8/EC of 8 February 2001 replacing
Annex I to Council Directive 92/109/EEC on the manufacture and
placing on the market of certain substances used in the illicit manu-
facture of narcotic drugs and psychotropic substances (OJ L 39,
9.2.2001, p. 31).

(4) Commission Directive 2003/101/EC of 3 November 2003
amending Council Directive 92/109/EEC on the manufacture and
placing on the market of certain substances used in the illicit manu-
facture of narcotic drugs and psychotropic substances (OJ L 286,
4.11.2003, p. 14).

(5) Commission Regulation (EC) No 1485/96 of 26 July 1996 laying
down detailed rules for the application of Council Directive 92/109/
EEC, as regards customer declarations of specific use relating to
certain substances used in the illicit manufacture of narcotic drugs
and psychotropic substances (OJ L 188, 27.7.1996, p. 28). Regu-
lation as amended by Regulation (EC) No 1533/2000 (OJ L 175,
14.7.2000, p. 75).

(6) Commission Regulation (EC) No 1533/2000 of 13 July 2000
amending Regulation (EC) No 1485/96 laying down detailed rules
for the application of Council Directive 92/109/EEC, as regards
customer declarations of specific use relating to certain substances
used in the illicit manufacture of narcotic drugs and psychotropic
substances.

18.2.2004

EN

Official Journal of the European Union

L 47/3

HAVE ADOPTED THIS REGULATION:

Article 1

Scope and objectives

This Regulation establishes harmonised measures for the intra-
Community control and monitoring of certain substances
frequently used for the illicit manufacture of narcotic drugs or
psychotropic substances with a view to preventing the diver-
sion of such substances.

Article 2

Definitions

For the purposes of this Regulation the following definitions
shall apply:

(a) ‘scheduled substance’ means any substance listed in Annex
I, including mixtures and natural products containing such
substances. This excludes medicinal products as defined by
Directive 2001/83/EC of the European Parliament and of
the Council of 6 November 2001 on the Community code
relating to medicinal products for human use (1), pharma-
ceutical preparations, mixtures, natural products and other
preparations containing scheduled substances
that are
compounded in such a way that they cannot be easily used
or extracted by readily applicable or economically viable
means;

(b) ‘non-scheduled substance’ means any substance which,
although not listed in Annex I, is identified as having been
used for the illicit manufacture of narcotic drugs or psycho-
tropic substances;

(c) ‘placing on the market’ means any supply, whether in
scheduled
return for payment or
substances in the Community; or the storage, manufacture,
production, processing, trade, distribution or brokering of
these substances for the purpose of supply in the Com-
munity;

free of charge, of

(d) ‘operator’ means any natural or legal person engaged in the

placing on the market of scheduled substances;

(e) ‘International Narcotics Control Board’ means the Board
established by the Single Convention on Narcotic Drugs,
1961, as amended by the 1972 Protocol;

(f) ‘special licence’ means a licence that is granted to a particu-

lar type of operator;

(g) ‘special registration’ means a registration that is made for a

particular type of operator.

substances, to notify the competent authorities of the name
and contact details of that officer and to notify them immedi-
ately of any subsequent modification of this information. The
officer shall ensure that
the trade in scheduled substances
conducted by the operator takes place in compliance with this
Regulation. The officer shall be empowered to represent the
operator and to take the decisions necessary for performing the
tasks specified above.

2.
Operators shall be required to obtain a licence from the
competent authorities before they may possess or place on the
market scheduled substances of category 1 of Annex I. Special
licences may be granted by the competent authorities to phar-
macies, dispensaries of veterinary medicine, certain types of
public authorities or armed forces. Such special licences shall
only be valid for the use of precursors within the scope of the
official duties of the operators concerned.

3.
Any operator holding a licence referred to in paragraph 2
shall supply scheduled substances of category 1 of Annex I
only to natural or legal persons who hold such a licence and
have signed a customer declaration as provided for in Article
4(1).

4. When considering whether to grant a licence, the compe-
tent authorities shall take into account in particular the compe-
tence and integrity of the applicant. The licence is to be refused
if there are reasonable grounds for doubting the suitability and
reliability of the applicant or of the officer responsible for the
trade in scheduled substances. The licence may be suspended
or revoked by the competent authorities whenever there are
reasonable grounds for believing that the holder is no longer a
fit and proper person to hold a licence, or that the conditions
under which the licence was granted are no longer fulfilled.

5. Without prejudice to Article 14, the competent authori-
ties may either limit the validity of the licence to a period not
exceeding three years or may oblige the operators to demon-
strate at intervals not exceeding three years that the conditions
under which the licence was granted are still fulfilled. The
licence shall mention the operation or operations for which it
is valid, as well as the substances concerned. Special licences
within the meaning of paragraph 2 shall be granted in principle
for an unlimited duration but may be suspended or revoked by
the competent authorities under the conditions of paragraph 4,
third sentence.

Article 3

Requirements for the placing on the market of scheduled
substances

1.
Operators wishing to place on the market scheduled
substances of categories 1 and 2 of Annex I shall be required
to appoint an officer responsible for the trade in scheduled

(1) OJ L 311, 28.11.2001, p. 67. Directive as last amended by Commis-

sion Directive 2003/63/EC (OJ L 159, 27.6.2003, p. 46).

6. Without prejudice to Article 6, operators engaged in the
placing on the market of scheduled substances of category 2 of
Annex I shall be required to register and update with the
competent authorities without delay the addresses of
the
premises at which they manufacture or from which they trade
in these substances, before placing them on the market. Phar-
macies, dispensaries of veterinary medicine, certain types of
public authorities or the armed forces may be made subject to
a special registration. Such registrations shall be considered
valid only for the use of precursors within the scope of the offi-
cial duties of the operators concerned.

L 47/4

EN

Official Journal of the European Union

18.2.2004

The competent authorities may require operators to pay a
7.
fee for the application for a licence or a registration. Such fees
shall be levied in a non-discriminatory way and shall not
exceed the cost of processing the application.

Article 4

Customer declaration

1. Without prejudice to Articles 6 and 14, any operator
established within the Community who supplies a customer
with a scheduled substance of categories 1 or 2 of Annex I
shall obtain a declaration from the customer which shows the
specific use or uses of the scheduled substances. A separate
declaration shall be required for each scheduled substance. This
declaration shall conform to the model set out in point 1 of
Annex III. In the case of legal persons, the declaration shall be
made on headed notepaper.

2.
As an alternative to the above declaration for an indivi-
dual transaction, an operator who regularly supplies a customer
with a scheduled substance of category 2 of Annex I may
accept a single declaration in respect of a number of transac-
tions involving this scheduled substance over a period not
exceeding one year, provided that the operator is satisfied that
the following criteria have been met:

(a) the customer has been supplied by the operator with the
substance on at least three occasions in the preceding 12
months;

(b) the operator has no reason to suppose that the substance

will be used for illicit purposes;

Commercial documents such as invoices, cargo manifests,
2.
administrative documents, transport and other shipping docu-
ments shall contain sufficient information to identify positively:

(a) the name of the scheduled substance as given in categories

1 and 2 of Annex I;

(b) the quantity and weight of the scheduled substance and,
where a mixture or natural product is concerned, the quan-
tity and weight,
the mixture or natural
product as well as the quantity and weight, or the percen-
tage by weight, of any substance or substances of categories
1 and 2 of Annex I which are contained in the mixture;

if available, of

(c) the name

and address of

supplier, distributor,
consignee, and,
if possible, of other operators directly
involved in the transaction, as referred to in Article 2(c)
and (d).

the

The documentation must also contain a customer declara-

3.
tion as referred to in Article 4.

4.
Operators shall keep such detailed records of their activ-
ities as are required to comply with their obligations under
paragraph 1.

5.
The documentation and records referred to in paragraphs
1 to 4 shall be kept for at least three years from the end of the
calendar year in which the transaction referred to in paragraph
1 took place, and must be readily available for inspection by
the competent authorities upon request.

The documentation may also be kept in the form of
6.
reproductions on an image medium or other data media. It
must be ensured that the data stored:

(c) the quantities ordered are consistent with the usual

consumption for that customer.

(a) match the documentation in appearance and content when

made readable, and

This declaration shall conform to the model set out in point 2
of Annex III. In the case of legal persons, the declaration shall
be made on headed notepaper.

3.
An operator supplying scheduled substances of category
1 of Annex I shall stamp and date a copy of the declaration,
certifying it to be a true copy of the original. Such copy must
always accompany category 1 substances being moved within
the Community and must be presented on request
to the
authorities responsible for checking vehicle contents during
transport operations.

Article 5

Documentation

1. Without prejudice to Article 6, operators shall ensure that
all transactions leading to the placing on the market of sched-
uled substances of categories 1 and 2 of Annex I are properly
documented in accordance with paragraphs 2 to 5 below. This
obligation shall not apply to those operators who hold special
licences or are subject to special registration pursuant to Article
3(2) and (6) respectively.

(b) are readily available at all times, can be made readable
without delay and can be analysed by automated means for
the duration of the period specified in paragraph 5.

Article 6

Exemptions

The obligations according to Articles 3, 4 and 5 shall not apply
to transactions involving scheduled substances of category 2 of
Annex I where the quantities involved do not exceed those
indicated in Annex II over a period of one year.

Article 7

Labelling

Operators shall ensure that
labels are affixed to scheduled
substances of categories 1 and 2 of Annex I before they are
supplied. The labels must show the names of the substances as
given in Annex I. Operators may in addition affix their
customary labels.

18.2.2004

EN

Official Journal of the European Union

L 47/5

Article 8

Notification of the competent authorities

1.
Operators shall notify the competent authorities immedi-
ately of any circumstances, such as unusual orders or transac-
tions involving scheduled substances to be placed on the
market, which suggest that such substances might be diverted
for the illicit manufacture of narcotic drugs or psychotropic
substances.

2.
Operators shall provide the competent authorities in
summary form with such information about their transactions
involving scheduled substances as is specified in implementing
measures adopted pursuant to Article 14.

Article 9

Guidelines

1.
In order to facilitate cooperation between the competent
authorities, the operators, and the chemical industry, in particu-
lar as regards non-scheduled substances, the Commission shall,
in accordance with the procedure referred to in Article 15(2),
draw up and update guidelines to assist the chemical industry.

2.

The guidelines shall provide in particular:

(a) information on how to recognise and notify suspect trans-

actions;

(b) a regularly updated list of non-scheduled substances to
enable the industry to monitor on a voluntary basis the
trade in such substances;

(c) other information which may be deemed useful.

3.
The competent authorities shall ensure that the guidelines
and the list of non-scheduled substances are regularly dissemi-
nated in a manner deemed appropriate by the competent
authorities in accordance with the objectives of the guidelines.

Article 10

Powers and obligations of competent authorities

1.
In order to ensure the correct application of Articles 3 to
8, each Member State shall adopt the measures necessary to
enable its competent authorities to perform their control and
monitoring duties, and in particular:

(a) to obtain information on any orders

for

scheduled

substances or operations involving scheduled substances;

(b) to enter operators' business premises in order to obtain

evidence of irregularities;

(c) where necessary,

to detain consignments

that

fail

to

comply with this Regulation.

The competent authorities shall respect confidential busi-

2.
ness information.

Article 11

Cooperation between the Member States and the Commis-
sion

Each Member State

1.
competent
authority or authorities responsible for ensuring the application
of this Regulation and shall inform the Commission thereof.

shall designate

the

For the purposes of applying this Regulation and without
2.
prejudice to Article 15, the provisions of Council Regulation
(EC) No 515/97 of 13 March 1997 on mutual assistance
between the administrative authorities of the Member States
and cooperation between the latter and the Commission to
ensure the correct application of the law on customs and agri-
cultural matters (1), and in particular those on confidentiality,
shall apply mutatis mutandis. The competent authority or autho-
rities designated under paragraph 1 of this Article shall act as
competent authorities within the meaning of Article 2(2) of
Regulation (EC) No 515/97.

Article 12

Penalties

The Member State shall lay down the rules on penalties applic-
able for infringement of the provisions of this Regulation and
shall take all measures necessary to ensure that they are imple-
mented. The penalties provided for must be effective, propor-
tionate and dissuasive.

Article 13

Communications from Member States

1.
To permit any necessary adjustments to the arrangements
for monitoring trade in scheduled substances and non-sched-
uled substances, the competent authorities in each Member
State shall each year communicate to the Commission all infor-
mation on the implementation of the monitoring measures laid
down in this Regulation,
in particular as regards substances
frequently used for the illicit manufacture of narcotic drugs or
psychotropic substances and methods of diversion and illicit
manufacture.

2.
A summary of the communications made pursuant to
paragraph 1 shall be submitted by the Commission to the Inter-
national Narcotics Control Board in accordance with Article
12(12) of the United Nations Convention and in consultation
with the Member States.

Article 14

Implementation

Where necessary, the following measures for the implementa-
tion of this Regulation shall be adopted in accordance with the
procedure referred to in Article 15(2):

(a) determination of the requirements and conditions for the
granting of the licence as provided for in Article 3 and the
details pertaining to the licence;

(b) determination, whenever necessary, of

conditions
which shall apply to the documentation and labelling of
mixtures and preparations containing substances listed in
Annex I, as provided for in Articles 5 to 7;

the

(1) OJ L 82, 22.3.1997, p. 1. Regulation as amended by Regulation

(EC) No 807/2003 (OJ L 122, 16.5.2003, p. 36).

L 47/6

EN

Official Journal of the European Union

18.2.2004

(c) any amendments to Annex I made necessary by amend-
ments to the tables in the Annex to the United Nations
Convention;

The Commission shall communicate this information to the
other Member States. It shall evaluate the implementation of
the Regulation three years after its entry into force.

(d) amendments to the thresholds set in Annex II;

(e) determination of

the requirements and conditions

for
customer declarations referred to in Article 4, as well as the
detailed rules concerning their use. This shall include rules
on how to provide customer declarations in electronic
form, where appropriate;

(f) other measures needed for the efficient implementation of

this Regulation.

Article 15

Committee

The Commission shall be assisted by the committee set

1.
up by Article 10 of Regulation (EEC) No 3677/90.

2. Where reference is made to this paragraph, Articles 4 and
7 of Decision 1999/468/EC shall apply, having regard to the
provisions of Article 8 thereof.

The period laid down in Article 4(3) of Decision 1999/468/EC
shall be set at three months.

3.

The Committee shall adopt its Rules of Procedure.

Article 16

Article 17

Repeals

1.
Council Directive 92/109/EEC, Commission Directives
93/46/EEC, 2001/8/EC and 2003/101/EC and Commission
Regulations (EC) No 1485/96 and (EC) No 1533/2000 are
hereby repealed.

References to the repealed directives or regulations shall

2.
be construed as being made to this Regulation.

The validity of any register established, any licences
the

3.
granted and any customer declarations
repealed directives or regulations shall not be affected.

issued under

Article 18

Entry into force

Information about measures adopted by Member States

Each Member State shall
the
measures it adopts pursuant to this Regulation, and in particu-
lar of the measures adopted pursuant to Articles 10 and 12.
They shall also notify any subsequent amendments thereof.

inform the Commission of

This Regulation shall enter into force on 18 August 2005,
except for Articles 9, 14 and 15, which shall enter into force
on the day of publication of this Regulation in the Official
Journal of the European Union, in order to permit the adoption of
the measures provided for in those Articles. Such measures
shall enter into force at the earliest on 18 August 2005.

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Strasbourg, 11 February 2004.

For the European Parliament

The President

P. COX

For the Council

The President

M. McDOWELL

18.2.2004

EN

Official Journal of the European Union

L 47/7

ANNEX I

Scheduled substances within the meaning of Article 2(a)

CATEGORY 1

Substance

CN designation
(if different)

CN code (1)

CAS No (2)

1-phenyl-2-propanone

Phenylacetone

2914 31 00

103-79-7

N-acetylanthranilic acid

2-acetamidobenzoic acid

2924 23 00

89-52-1

Isosafrol (cis + trans)

3,4-methylenedioxyphenyl-
propan-2-one

1-(1,3-Benzodioxol-5-
yl)propan-2-one

Piperonal

Safrole

Ephedrine

Pseudoephedrine

Norephedrine

Ergometrine

Ergotamine

Lysergic acid

2932 91 00

120-58-1

2932 92 00

4676-39-5

2932 93 00

120-57-0

2932 94 00

94-59-7

2939 41 00

299-42-3

2939 42 00

90-82-4

ex 2939 49 00

14838-15-4

2939 61 00

60-79-7

2939 62 00

113-15-5

2939 63 00

82-58-6

The stereoisomeric forms of the substances listed in this category not being cathine (3), whenever the existence of such
forms is possible.

The salts of the substances listed in this category, whenever the existence of such salts is possible and not being the salts
of cathine.

(1) OJ L 290, 28.10.2002, p. 1.
(2) The CAS No is the ‘chemical abstracts service registry number’, which is a unique numeric identifier specific to each substance and its
structure. The CAS No is specific to each isomer and to each salt of each isomer. It must be understood that the CAS Nos for the
salts of the substances listed above will be different to those given.

(3) Also named (+)-norpseudoephedrine, CN code 2939 43 00, CAS No 492-39-7.

CATEGORY 2

Substance

CN designation
(if different)

CN code (1)

CAS No (2)

Acetic anhydride

Phenylacetic acid

Anthranilic acid

Piperidine

2915 24 00

108-24-7

2916 34 00

103-82-2

2922 43 00

118-92-3

2933 32 00

110-89-4

Potassium permanganate

2841 61 00

7722-64-7

The salts of the substances listed in this category, whenever the existence of such salts is possible.

(1) OJ L 290, 28.10.2002, p. 1.
(2) The CAS No is the ‘chemical abstracts service registry number’, which is a unique numeric identifier specific to each substance and its
structure. The CAS No is specific to each isomer and to each salt of each isomer. It must be understood that the CAS Nos for the
salts of the substances listed above will be different to those given.

L 47/8

EN

Official Journal of the European Union

18.2.2004

CATEGORY 3

Substance

CN designation
(if different)

CN code (1)

CAS No (2)

Hydrochloric acid

Sulphuric acid

Toluene

Ethyl ether

Acetone

Hydrogen chloride

Diethyl ether

Methylethylketone

Butanone

2806 10 00

2807 00 10

2902 30 00

2909 11 00

2914 11 00

2914 12 00

7647-01-0

7664-93-9

108-88-3

60-29-7

67-64-1

78-93-3

The salts of the substances listed in this category, whenever the existence of such salts is possible and not being the salts
of hydrochloric acid and sulphuric acid.

(1) OJ L 290, 28.10.2002, p. 1.
(2) The CAS No is the ‘chemical abstracts service registry number’, which is a unique numeric identifier specific to each substance and its
structure. The CAS No is specific to each isomer and to each salt of each isomer. It must be understood that the CAS Nos for the
salts of the substances listed above will be different to those given.

Substance

Acetic anhydride

Potassium permanganate

Anthranilic acid and its salts

Phenylacetic acid and its salts

Piperidine and its salts

ANNEX II

Threshold

100 l

100 kg

1 kg

1 kg

0,5 kg

18.2.2004

EN

Official Journal of the European Union

L 47/9

1. Model declaration relating to individual transactions (category 1 or 2)

ANNEX III

L 47/10

EN

Official Journal of the European Union

18.2.2004

2. Model declaration relating to multiple transactions (category 2)